Providing evidence to inform policy: Pioneering the use of DOT for STH chemotherapy amongst expectant mothers attending antenatal clinics in rural coastal Kenya

Research question

1. What is the positivity rate of STH among pregnant mothers attending the ANC?
2. What is the difference in the STH burden in women who receive DOT and those who receive standard of care?
3. How acceptable is the DOT strategy in administering mebendazole among health care providers?
4. What is the information gap on STH preventive measures experienced by expectant mothers attending ANC clinics in Kilifi county?
 

Study sites

Notes

Grant awardee: Rodgers Onsomu Moindi

Contact

Other collaborator(s)

Reference information

NTD-SC #
SGP IV

Tags

Disease(s)
Soil-transmitted helminthiasis
Research topic(s)
Surveillance